HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

L’Oréal Anti-Aging Molecule Reinforces Skin Matrix – Researcher

This article was originally published in The Rose Sheet

Executive Summary

L'Oréal has developed a new anti-aging molecule called pro-xylane, which reinforces the extracellular matrix of skin, according to L'Oréal Senior VP Research and Development Alan Meyers
Advertisement

Related Content

New L'Oreal/Garnier Products Include Roller-Ball Moisturizing Massager
New L'Oreal/Garnier Products Include Roller-Ball Moisturizing Massager
La Roche-Posay’s Substiane Cream Contains Most Pro-Xylane Available OTC
La Roche-Posay’s Substiane Cream Contains Most Pro-Xylane Available OTC
Lancôme Unveils “Technologically Advanced” Anti-Aging Treatment
Retinol Derivative Treats Photodamaged Skin Without Side Effects – Study
Lancôme Unveils “Technologically Advanced” Anti-Aging Treatment
Retinol Derivative Treats Photodamaged Skin Without Side Effects – Study
AAD Annual Meeting In Brief
AAD Annual Meeting In Brief
Advertisement
UsernamePublicRestriction

Register

RS014015

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel